Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Result of Placing

7th Jun 2012 15:39

RNS Number : 9305E
Synergy Health PLC
07 June 2012
 



7 June 2012

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN

 

 

Synergy Health Plc ("Synergy Health" or "the Company")

 

Result of Accelerated Bookbuild (the "Placing")

 

 

Further to the earlier announcement in relation to the proposed placing of ordinary shares, the Company announces that 2,755,520 ordinary shares (the "Placing Shares") have been placed with institutional investors, a trust ("Trust") of which Dr Richard Steeves, Chief Executive Officer of Synergy Health, is the primary beneficiary, and Gavin Hill, Finance Director of Synergy Health.

 

The shares were placed at a price of 820p per share via an accelerated bookbuild placing managed by Investec. The Placing raised approximately £22.6 million before expenses.

 

Both the Trust and Mr Hill are deemed under the Listing Rules to be related parties to Synergy Health. Due to the size of both of their respective participations in the Placing, shareholder approval is not required.

 

As a result of the Trust's acquisition of 1,206,030 of the Placing Shares, Dr. Steeves now has an interest in 1,813,845 ordinary shares in the Company, representing 3.12 per cent of the issued share capital. In addition, Mr. Hill, who acquired 6,100 ordinary shares as part of the Placing now has an interest in 30,400 ordinary shares in the Company, representing 0.05 per cent of the issued share capital as enlarged by the Placing.

 

Application has been made for the admission of 2,755,520 ordinary shares to the premium segment of the Official List of the FSA and to the London Stock Exchange for admission to trading of the ordinary shares on its main market for listed securities. It is expected that admission will become effective at 8.00 a.m. on 12 June 2012 and that dealings in the ordinary shares will commence at that time. The shares shall rank pari passu with the existing issued ordinary shares of the Company including the right to receive the proposed final dividend of 11.18 pence per share announced this morning.

Enquiries

Synergy Health Plc

Dr. Richard Steeves Chief Executive Officer Tel: 01793 891 891

Gavin Hill Finance Director

 

Investec Bank plc Tel: 0207 597 5970

Patrick Robb

Daniel Adams

Carlton Nelson

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUBOSRUBANRAR

Related Shares:

SYR.L
FTSE 100 Latest
Value8,596.35
Change99.55